Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06625190
What this trial is testing

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaSynovial Sarcoma+11 more
University of Florida 27
Early research (Phase 1)Study completedNCT00002705
What this trial is testing

Topotecan in Treating Children With Refractory Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Looking for participantsNCT07362238
What this trial is testing

Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 122
Early research (Phase 1)WithdrawnNCT05134740
What this trial is testing

(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).

Who this might be right for
Hodgkins LymphomaNon Hodgkins Lymphoma
Baylor College of Medicine
Testing effectiveness (Phase 2)Study completedNCT05302921
What this trial is testing

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Who this might be right for
OsteosarcomaEwing SarcomaRhabdomyosarcoma+7 more
Children's National Research Institute 5
Testing effectiveness (Phase 2)UnknownNCT02901145
What this trial is testing

Nivolumab in Relapsed Pediatric Solid Tumors

Who this might be right for
Antibodies, Neoplasm
Hadassah Medical Organization 30
Not applicableLooking for participantsNCT05504772
What this trial is testing

Precision Medicine for Every Child With Cancer

Who this might be right for
Childhood CancerChildhood Solid TumorChildhood Brain Tumor+3 more
Australian & New Zealand Children's Haematology/Oncology Group 3,500
Early research (Phase 1)Study completedNCT00991133
What this trial is testing

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Lymphoblastic Leukemia, Acute, Childhood
Genzyme, a Sanofi Company 8
Early research (Phase 1)Study completedNCT00462787
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT07387926
What this trial is testing

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 50
Not applicableUnknownNCT04033627
What this trial is testing

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

Who this might be right for
Relapsed Pediatric ALLAcute Graft-Versus-Host Disease (Gvhd) Grade IV (Diagnosis)Relapsed Pediatric AML
Shanghai Children's Medical Center 30
Very early researchUnknownNCT04173988
What this trial is testing

Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
ALL, Childhood B-Cell
Children's Hospital of Fudan University 6
Large-scale testing (Phase 3)Study completedNCT02283853
What this trial is testing

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 156
Not applicableApproved For MarketingNCT05760586
What this trial is testing

Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma

Who this might be right for
Low-grade Glioma
Day One Biopharmaceuticals, Inc.
Not applicableApproved For MarketingNCT03245424
What this trial is testing

Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation

Who this might be right for
Acute Myeloid LeukemiaRelapsed Adult AMLRelapsed Pediatric AML
Agios Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT01492088
What this trial is testing

Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaRelapsed or Refractory Anaplastic Large-cell Lymphoma
Millennium Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT02748135
What this trial is testing

TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

Who this might be right for
Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)
Oncurious NV 18
Early research (Phase 1)Looking for participantsNCT06173518
What this trial is testing

CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Who this might be right for
Relapsed or Refractory B Cell Acute Lymphoblastic LeukemiaRelapsed or Refractory B Cell Non-Hodgkin Lymphoma
Autolus Limited 30
Early research (Phase 1)WithdrawnNCT05622591
What this trial is testing

ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML

Who this might be right for
Acute Myeloid LeukemiaAML, ChildhoodRelapsed Pediatric AML+1 more
Elucida Oncology
Early research (Phase 1)Ended earlyNCT03451825
What this trial is testing

Phase I/II Study of Avelumab in Pediatric Cancer Participants

Who this might be right for
Refractory or Relapsed Solid TumorsLymphoma
EMD Serono Research & Development Institute, Inc. 21
Next Page